Ferring Pharmaceuticals
Bowel preparation for pediatric colonoscopy.
Inclusion Criteria: * Male or female, aged 12 months to \<9 years being scheduled to undergo elective colonoscopy. * Weight ≥10 kg (≥22 lbs). * Participants must have had regular spontaneous bowel movements (SBM) weekly for 1 month prior to the colonoscopy. * Written informed consent (by parent(s)/ caregiver(s)/ guardian(s)) and assent (if applicable) obtained at screening. Exclusion Criteria: * History of significant liver, cardiovascular, or renal disease (including recent or ongoing oliguria). * Acute surgical abdominal conditions (e.g., acute obstruction or perforation) during the scree…
CLENPIQ consists of sodium picosulfate 10.0 mg + magnesium oxide 3.5 g + citric acid, anhydrous 12.0 g. Supplied as a pre-mixed, ready-to-drink oral solution in two bottles, each containing 160 mL.
MIRALAX powder for oral solution, supplied in a 8.3 oz multi-dose bottle containing 238 g of laxative powder (polyethylene glycol \[PEG\] 3350). MIRALAX is mixed with non-carbonated, clear beverage, or water and consumed at specified intervals until the total required dose.
SENNA Liquid (chocolate flavor) is an oral solution to be taken according to body weight (8.8 mg for 10-22 kg, 17.6 mg for 22-34 kg and 26.4 mg for \>34 kg) prior to MIRALAX.
Arctuva estimate
Verify or correct the compensation shown for this listing.